Jove
Visualize
Contact Us

Related Experiment Videos

Progress and potential for gene-based medicines.

M R Dyer1, P L Herrling

  • 1Novartis Pharma AG, Basel, Switzerland.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|August 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice.

Journal of thrombosis and haemostasis : JTH·2016
Same author

From genome to therapy: industry perspective.

Novartis Foundation symposium·2000
Same author

Building a competitive functional genomics platform.

Nature biotechnology·1999
Same author

Extracts from rhizomes of Cyperus articulatus (Cyperaceae) displace [3H]CGP39653 and [3H]glycine binding from cortical membranes and selectively inhibit NMDA receptor-mediated neurotransmission.

Journal of ethnopharmacology·1996
Same author

Thalamocortical and corticocortical excitatory postsynaptic potentials mediated by excitatory amino acid receptors in the cat motor cortex in vivo.

Neuroscience·1995
Same author

Sequences of members of the human gene family for the c subunit of mitochondrial ATP synthase.

The Biochemical journal·1993
Same journal

Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Endothelial injury with capillary leak: A final common pathway in acute AAV toxicity?

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Long-term functional synaptic integration of genome-edited retinal organoids in a primate model of macular degeneration.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Nox1/4 inhibitor Setanaxib treatment ameliorates cardiac function in mouse models of Duchenne Muscular Dystrophy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

HSP90α-USP7-DNMT1 Axis Drives Hepatocellular Carcinoma Recurrence After Microwave Ablation by Disrupting ACSS3-Mediated Propionate Metabolism.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Cell-penetrating asymmetric siRNA targeting MyD88 suppresses inflammasome-driven ocular degeneration and angiogenesis.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Gene-based medicines show promise for disease prevention and management, despite challenges. Advances in xenotransplantation may also provide gene-modified organs for human transplants, addressing donor organ shortages.

Area of Science:

  • Biotechnology
  • Genetics
  • Transplantation Medicine

Background:

  • Gene-based medicines offer novel therapeutic potential beyond traditional chemical and protein treatments.
  • Progress in gene therapy has been hindered by limited disease genetic understanding, complex biological agent development, and rigorous safety testing.
  • The field faces technological hurdles and clinical setbacks, impacting the pace of innovation.

Purpose of the Study:

  • To explore the future potential of gene-based medicines in disease prevention and management.
  • To highlight the emerging role of xenotransplantation in addressing the shortage of human donor organs.
  • To discuss the integration of gene-modified porcine organs for human transplantation.

Main Methods:

  • Review of current research in gene therapy and its challenges.

Related Experiment Videos

  • Analysis of advancements in xenotransplantation and genetic modification techniques.
  • Exploration of potential clinical applications and future directions.

    • Main Results:

    • Gene-based medicines are expected to expand treatment options for unmet medical needs within the next decade.
    • Gene-modified porcine organs present a viable solution to the critical shortage of human donor organs.
    • Xenotransplantation research is progressing towards clinical application.

    Conclusions:

    • Gene therapy, despite current challenges, is poised to become a significant part of future healthcare strategies.
    • Xenotransplantation, particularly using gene-modified organs, offers a promising avenue to overcome organ scarcity.
    • Continued research and development are crucial for realizing the full potential of these advanced medical modalities.